M & As this week: Genesis Biotechnology Group, Betta Pharmaceuticals

Genesis Biotechnology Group has completed the acquisition of PharmOptima, which will enable the former to provide its customers a single point-of-contact for the development and co-ordination of their unique pre-clinical drug development programme.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news